NCT07407647 2026-02-12
Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer
Ohio State University Comprehensive Cancer Center
Phase 2 Recruiting
Clinical Trials
12 trialsNCT05562518 2025-07-23
GRACE
University Hospital, Ghent
Phase 4 Recruiting
NCT04493333 2024-11-27
Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors
University of Arkansas
Phase 2 Terminated
NCT06611514 2024-11-19
PROPOSE
European Institute of Oncology
Phase 3 Not yet recruiting
NCT05263557 2023-07-25
DIMOXIS
Royal College of Surgeons, Ireland
Phase NA Unknown
NCT05246865 2022-11-02
11OXO-PCOS
University of Birmingham
Phase NA Unknown
NCT04705883 2022-02-22
VIBRA
Hospital Clinic of Barcelona
Phase 4 Completed
NCT03740945 2020-07-31
Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer
EndoCeutics Inc.
Phase 3 Withdrawn
NCT00972023 2019-09-17
DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer
Barbara Ann Karmanos Cancer Institute
Phase 1 Terminated
NCT02683148 2019-09-09
DHEA in Synovial Sarcoma Patients
Washington University School of Medicine
Phase 1 Terminated
NCT01376349 2019-02-07
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00516542 2012-07-24
Dehydroepiandrosterone (DHEA) and Letrozole in Treating Patients With Metastatic Breast Cancer
OHSU Knight Cancer Institute
Phase 1 Terminated